Skip to content

Cognitive profiles: psychopathy & substance abuse

Cognitive profiles: psychopathy & substance abuse - Cognitive profiles

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50233
Enrollment
300
Registered
2020-07-30
Start date
2018-02-05
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

addiction psychopathy

Interventions

Addiction
Antisocial behaviour
Neuropsychology
Psychopathy

Sponsors

Erasmus Universiteit Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: All (wo)men aged 18-65 incarcerated in or in treatment at the partcipating (forensic) psychiatric facilities, who have signed an informed consent form, including: - personality disordered patients; - addicted patients; - patients with all other psychiatric disorders, besides psychotic disorders; - delinquents with known disorder; - delinquents without (knwon) disorder; - healthy people recruited from general population, who don't meet exclusion criteria;

Exclusion criteria

Exclusion criteria: - Schizofrenic / active psychotic patients or bipolar disorderd patients with psychotic features - adminstered use of anti-psychotic medication; - colorblindness of other visual impairment - IQ 65, - controlgroep: * AUDIT-score >20 (indicatief voor alcoholafhankelijkheid) * DUDIT-score >25 (indicatief voor drugsafhankelijkheid)

Design outcomes

Primary

MeasureTime frame
Examined is wether psychopathic patients (PCL-R totalscore >25) and addicted patients PCL-R-score * 25 & primary DSM-classification of a Substance Use Disorder) can be distinguished, based on a cognitive profile of their individual performance (measured in reaction time and accuracy) on five experimental tasks.

Secondary

MeasureTime frame
Examined is wether in patients, which are classified as having a 'double diagnosis' (i.e. being diagnosed with both psychopathy (PCL-R totalscore >25) and a substance use disorder (DSM-classification), there primary diagnoses can be distinguished based on their cognitive profile. In the regression model, age, intelligence, medication, personality and performance on the neuropsychological screening are added as covariables in order to clarify the unique predictive validity of the experimental tasks.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)